Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity
Summary Objective Abdominal fat ultrasound (US) is a simple clinical tool that may allow measures of fat depots not visible using common dual‐energy X‐ray absorptiometry (DEXA) or computerized tomography (CT) imaging. The aim of this study was to validate the technique, give measures of superficial...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-12-01
|
| Series: | Obesity Science & Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/osp4.453 |
| _version_ | 1797795316961902592 |
|---|---|
| author | Guillem Cuatrecasas Francisco deCabo Maria Josep Coves Ioana Patrascioiu Gerardo Aguilar Sonia March Mariona Balfegó Clara Bretxa Marta Calbo Gabriel Cuatrecasas Gloria Aranda Aida Orois Isabel Bové Elena Munoz‐Marron Pilar García‐Lorda |
| author_facet | Guillem Cuatrecasas Francisco deCabo Maria Josep Coves Ioana Patrascioiu Gerardo Aguilar Sonia March Mariona Balfegó Clara Bretxa Marta Calbo Gabriel Cuatrecasas Gloria Aranda Aida Orois Isabel Bové Elena Munoz‐Marron Pilar García‐Lorda |
| author_sort | Guillem Cuatrecasas |
| collection | DOAJ |
| description | Summary Objective Abdominal fat ultrasound (US) is a simple clinical tool that may allow measures of fat depots not visible using common dual‐energy X‐ray absorptiometry (DEXA) or computerized tomography (CT) imaging. The aim of this study was to validate the technique, give measures of superficial and profound subcutaneous, preperitoneal, omental and perirenal (retroperitoneal) fat and correlate them with MS markers. Methods Sequential US measures of these five abdominal fat layers were done at 397 adults. Blood pressure (BP), body mass index (BMI), waist, body fat %, HOMA‐IR index (homeostatic model assessment of insulin resistance), lipid profile and leptin were recorded. Metabolic syndrome (MS) was defined according to Cholesterol education programme adult treatment panel III (ATPIII) criteria. Results Subcutaneous and omental fat were increased among people with obesity, whereas preperitoneal and perirenal fat did not show any difference according to BMI or waist. Women showed thicker subcutaneous fat (both superficial and profound), whereas men had bigger omental fat. Both postmenopausal and diabetic patients had changes in omental fat only, whereas patients with fatty liver showed thicker preperitoneal and perirenal fat, as well. MS patients showed both thicker perirenal and omental fat. A cut‐off of 54 mm in male (M)/34 mm in female (F) of omental fat and 22.5 mm (M)/12.5 mm (F) of perirenal fat could be predictive of later MS onset. Conclusions US is a valid method to measure all different abdominal fat depots. Omental and perirenal fat measures may classify patients at risk for MS. Preperitoneal fat depot may also correlate with fatty liver disease. |
| first_indexed | 2024-03-13T03:16:04Z |
| format | Article |
| id | doaj.art-67a3717b47d0474da2c665ea493792c1 |
| institution | Directory Open Access Journal |
| issn | 2055-2238 |
| language | English |
| last_indexed | 2024-03-13T03:16:04Z |
| publishDate | 2020-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Obesity Science & Practice |
| spelling | doaj.art-67a3717b47d0474da2c665ea493792c12023-06-26T04:06:50ZengWileyObesity Science & Practice2055-22382020-12-016666066710.1002/osp4.453Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesityGuillem Cuatrecasas0Francisco deCabo1Maria Josep Coves2Ioana Patrascioiu3Gerardo Aguilar4Sonia March5Mariona Balfegó6Clara Bretxa7Marta Calbo8Gabriel Cuatrecasas9Gloria Aranda10Aida Orois11Isabel Bové12Elena Munoz‐Marron13Pilar García‐Lorda14Endocrinology Department Clinica Sagrada Familia Barcelona SpainRadiology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainEndocrinology Department Clinica Sagrada Familia Barcelona SpainRadiology Department Clinica Sagrada Familia Barcelona SpainFaculty Health Sciences Universitat Oberta Catalunya Barcelona SpainFaculty Health Sciences Universitat Oberta Catalunya Barcelona SpainSummary Objective Abdominal fat ultrasound (US) is a simple clinical tool that may allow measures of fat depots not visible using common dual‐energy X‐ray absorptiometry (DEXA) or computerized tomography (CT) imaging. The aim of this study was to validate the technique, give measures of superficial and profound subcutaneous, preperitoneal, omental and perirenal (retroperitoneal) fat and correlate them with MS markers. Methods Sequential US measures of these five abdominal fat layers were done at 397 adults. Blood pressure (BP), body mass index (BMI), waist, body fat %, HOMA‐IR index (homeostatic model assessment of insulin resistance), lipid profile and leptin were recorded. Metabolic syndrome (MS) was defined according to Cholesterol education programme adult treatment panel III (ATPIII) criteria. Results Subcutaneous and omental fat were increased among people with obesity, whereas preperitoneal and perirenal fat did not show any difference according to BMI or waist. Women showed thicker subcutaneous fat (both superficial and profound), whereas men had bigger omental fat. Both postmenopausal and diabetic patients had changes in omental fat only, whereas patients with fatty liver showed thicker preperitoneal and perirenal fat, as well. MS patients showed both thicker perirenal and omental fat. A cut‐off of 54 mm in male (M)/34 mm in female (F) of omental fat and 22.5 mm (M)/12.5 mm (F) of perirenal fat could be predictive of later MS onset. Conclusions US is a valid method to measure all different abdominal fat depots. Omental and perirenal fat measures may classify patients at risk for MS. Preperitoneal fat depot may also correlate with fatty liver disease.https://doi.org/10.1002/osp4.453metabolic syndromeomentalsubcutaneous adipose tissueultrasound |
| spellingShingle | Guillem Cuatrecasas Francisco deCabo Maria Josep Coves Ioana Patrascioiu Gerardo Aguilar Sonia March Mariona Balfegó Clara Bretxa Marta Calbo Gabriel Cuatrecasas Gloria Aranda Aida Orois Isabel Bové Elena Munoz‐Marron Pilar García‐Lorda Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity Obesity Science & Practice metabolic syndrome omental subcutaneous adipose tissue ultrasound |
| title | Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity |
| title_full | Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity |
| title_fullStr | Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity |
| title_full_unstemmed | Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity |
| title_short | Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity |
| title_sort | ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity |
| topic | metabolic syndrome omental subcutaneous adipose tissue ultrasound |
| url | https://doi.org/10.1002/osp4.453 |
| work_keys_str_mv | AT guillemcuatrecasas ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT franciscodecabo ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT mariajosepcoves ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT ioanapatrascioiu ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT gerardoaguilar ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT soniamarch ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT marionabalfego ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT clarabretxa ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT martacalbo ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT gabrielcuatrecasas ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT gloriaaranda ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT aidaorois ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT isabelbove ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT elenamunozmarron ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity AT pilargarcialorda ultrasoundmeasuresofabdominalfatlayerscorrelatewithmetabolicsyndromefeaturesinpatientswithobesity |